Plaintiffs, Pfizer Spar Over Where To Join Depo-Provera Suits

By Carolina Bolado · January 30, 2025, 9:14 PM EST

Consumers who claim Pfizer Inc. failed to adequately warn patients and doctors about the risk of brain tumors associated with the hormonal contraceptive drug Depo-Provera urged the U.S. Judicial Panel on...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

IN RE: Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation

Case Number

Court

Judicial Panel on Multidistrict Litigation

Nature of Suit

Date Filed

November 26, 2024

Recent Articles By Carolina

January 31, 2025
Pharmacy Escapes Novo Nordisk's Suit Over Ozempic
January 02, 2025
1st Private Co. Joins Insulin Price-Fixing MDL
December 05, 2024
Pain Management Clinic Fined $1.19 Million for HIPAA Breach
November 12, 2024
Consultant In $213M 'Maya' Trial Says Atty Ducked Bill
November 05, 2024
Fla. Abortion Rights Measure Fails With Support Below 60%
October 29, 2024
Judge Extends Block On Florida's Threats Over Abortion Ad
October 22, 2024
Fla. Says 1st Amendment Doesn't Protect 'False' Abortion Ad
October 21, 2024
Fla. Dept.'s Ex-GC Says Gov.'s Office Directed TV Ad Letters
October 18, 2024
Suit Wants Fla. Abortion Measure Struck Over Fraud Claims
October 01, 2024
Ga. County Urges Full 11th Circ. To Nix Trans Deputy's Win